Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
about
Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs)Sugar-coated sperm: Unraveling the functions of the mammalian sperm glycocalyxA chronological expression profile of gene activity during embryonic mouse brain developmentDivergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid AThe "CPC clip motif": a conserved structural signature for heparin-binding proteins.The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis.Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.Workflow for combined proteomics and glycomics profiling from histological tissuesInvestigation of glycan evolution based on a comprehensive analysis of glycosyltransferases using phylogenetic profiling.Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathologyRegulation of cerebral cholesterol metabolism in Alzheimer disease.Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease.Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases.Pathological significance of ganglioside clusters in Alzheimer's disease.Manipulating the extracellular matrix and its role in brain and spinal cord plasticity and repair.Misfolding of amyloidogenic proteins and their interactions with membranes.Sugar glues for broken neuronsThe effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.Food-Derived Antioxidant Polysaccharides and Their Pharmacological Potential in Neurodegenerative Diseases.Molecular Origins of the Compatibility between Glycosaminoglycans and Aβ40 Amyloid FibrilsProteoglycans and their heterogeneous glycosaminoglycans at the atomic scale.The Multimerization State of the Amyloid-β42 Amyloid Peptide Governs its Interaction Network with the Extracellular Matrix.Influence of heparin molecular size on the induction of C- terminal unfolding in β2-microglobulin.Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy.Regulation of xylosyltransferase I gene expression by interleukin 1β in human primary chondrocyte cells: mechanism and impact on proteoglycan synthesis.Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.Critical Influence of Cosolutes and Surfaces on the Assembly of Serpin-Derived Amyloid Fibrils.Learning from Synthetic Models of Extracellular Matrix; Differential Binding of Wild Type and Amyloidogenic Human Apolipoprotein A-I to Hydrogels Formed from Molecules Having Charges Similar to Those Found in Natural GAGs.Inhibiting, promoting, and preserving stability of functional proteinfibrils
P2860
Q26823798-5787CAD4-2688-4FA4-B696-FC1D131FAF75Q27001029-0933E9F8-A468-4B8E-BC7C-1BB368765B66Q30558093-E69124B8-EE62-40C4-9B93-E2C7042407ACQ33993673-D6C92DD6-E61F-497A-8457-526C3EB50760Q34374614-255F333F-C96F-4946-8804-95D793657087Q34512696-28CD7361-77FA-4F63-A4D7-16808108EAADQ34743986-BD2A18C3-1A7B-4EB6-9FC8-F145CBE298E7Q35180876-33B2C974-BADF-4943-88D7-4A8C4B57F963Q35592825-8E80B128-82C8-474F-A3B0-C0B7AE968176Q36531717-B1606318-4255-427C-B2C1-6B401A97ED82Q36803086-B7099936-64EC-43D2-B3F0-A95BAA2686BCQ36841850-FCCFB1EA-0CAE-45C6-BEA5-ACDF48FC1B34Q37241399-104F332F-97FE-42C0-9088-38653C071BFDQ37721141-B5BC6B2E-ECC9-4B00-BEC9-05748090C2EBQ37826772-791F52DB-667E-48DB-ACC6-C8B4AB7CBA82Q38179520-5D0D4C32-DC91-4EAC-9639-672DB927C8E1Q38223686-94F4A3C3-FBF4-4FA9-97A9-5F0EA2AF1CECQ38256971-FA5AB425-FB2F-448D-B880-8B4F5EDBA530Q38343014-80DAB2D1-7587-4CAF-8ACA-D90D1870AC72Q38658691-C75C92D8-1DC6-44CE-8B96-595BD7D3757EQ41195586-0DE2EFA4-9915-4F87-90C4-C543113E1425Q41301732-5907C190-C222-457C-9E0C-7A73FC2941FDQ41978020-3DAA248E-5A06-474A-A10C-7FDF4A7592C6Q42152328-3340145D-DB55-4B17-AA23-5423A5A0BB98Q42319844-50E01809-B8F8-44A4-A3F1-18F274B8D51CQ42703458-BC52441F-B2EF-4521-AADC-AA7A6EC79BD4Q42798764-72D17655-25FF-48DB-B9B7-8BF898707E5AQ44241652-82338038-06B6-47A8-AD51-C868D45E3B5CQ46323407-2CE83BA8-6890-4BAB-98EF-5E401E3117DBQ48247953-C7E8CBD8-890D-41FF-A8B5-C09B73E7F5BBQ57364071-D67DA342-C029-4FFD-BA05-ADE0E4E34356
P2860
Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of proteoglycans and glyc ...... rapeutic strategies--a review.
@en
Role of proteoglycans and glyc ...... rapeutic strategies--a review.
@nl
type
label
Role of proteoglycans and glyc ...... rapeutic strategies--a review.
@en
Role of proteoglycans and glyc ...... rapeutic strategies--a review.
@nl
prefLabel
Role of proteoglycans and glyc ...... rapeutic strategies--a review.
@en
Role of proteoglycans and glyc ...... rapeutic strategies--a review.
@nl
P2093
P2860
P356
P1476
Role of proteoglycans and glyc ...... rapeutic strategies--a review.
@en
P2093
Robert K Yu
Tadashi Miyatake
Toshio Ariga
P2860
P304
P356
10.1002/JNR.22393
P577
2010-08-01T00:00:00Z